egwps

Logo

April 17, 2026

PCP Stability In Doubt Elation Health finds that over 80% of primary care physicians (PCPs) are concerned about financial stability over the next several years. The company surveyed 280 PCPs from Jan. 31 to Feb. Fifty-two percent of respondents were fully independent and 48% have some affiliation.  About 64% cite government and commercial payer reimbursement as their top concern. Staffing costs, workforce challenges, technology and IT costs and rising operational costs are also challenges. Despite all this, 93% of respondents report remaining committed to primary care. Only 2% report planning to leave the practice.  #providers #physicians #margins https://www.fiercehealthcare.com/providers/over-80-pcps-concerned-about-financial-stability-over-next-several-years-elation-health Employer Affordability Challenges Purchaser Business Group on Health finds that more and more employers are considering switching insurance or pharmacy benefits managers (PBMs) as a result of rising costs. About 37% of members have issued request for proposals (RFP) for medical benefits, meaning they’re shopping between insurance providers. About 23% are conducting

Read More »
Logo

April 16, 2026

Trump Getting Serious On Affordability There was a clear sign today that the Trump administration is worried about the impact of the lack of healthcare affordability. The Trump administration created a top-level healthcare position that will be a de facto affordability czar. Health and Human Services Secretary Robert F. Kennedy, Jr. has named Casey Mulligan as chief economist and chief regulatory officer of the agency. He’ll advise Kennedy and other agency leaders on affordability issues. Mulligan was on the Council of Economic Advisers during the first Trump administration and was most recently the U.S. Small Business Administration’s chief counsel for advocacy. Meanwhile, healthcare policy group KFF issued a briefer on Americans’ views of healthcare. Just under half of U.S. adults say it is difficult to afford healthcare costs, and about three in ten say they or a family member in their household had problems paying for healthcare in the past

Read More »

Stars Plan Does Not Change In 2027 Final Announcement

NOTE: Co-published in partnership with Lilac Software. See more on Lilac at the end of the blog. 2027 Final Announcement makes no changes on Stars from the Advance Notice While the Medicare Advantage (MA) industry is facing major upheaval through Star Year 2029 due to the finalization of the MA and Part D 2027 rule, the coming year’s Final Announcement of rates and policies is very status quo from a Stars perspective. I have gone back to compare the Advance Notice and Final Announcement and here remains the all-important updates for Star Year 2027 and technical changes or proposals for future years. Go to my February 2, 2026 blog here for more details: https://www.healthcarelabyrinth.com/stars-changes-in-2027-advance-notice/ Deadline Calendar/Reminders for Star Year (SY) 2027 and SY 2028 For Measure Years (MY) 2025/SY 2027: For MY/2026/SY 2028: Note that these data review deadlines are before PDE and Appeals (at least for Reopens) have final

Read More »
Logo

April 15, 2026

Chronic Care Cost-Sharing Targeted A new bill would eliminate Medicare cost-sharing on care coordination services. Supporters argue the cost-sharing on the services creates financial barriers to deploying such services for many. They also argue charging seniors for the behind-the-scenes services is confusing. Further, the services have documented savings, but utilization is low due to the cost-sharing impediment. About 40 healthcare and patient groups have endorsed the measure. #chroniccare #medicare https://www.fiercehealthcare.com/providers/providers-back-new-bipartisan-bill-eliminating-medicare-chronic-care-management-cost Wegovy Gets Boost GoodRx is making available the new higher 7.2 mg dose of Wegovy for weight loss at $399 per month. This is a boost to embattled drug maker Novo Nordisk, which has lost major market share in the weight-loss drug market to Eli Lilly. #weightlossdrugs #drugpricing https://www.fiercehealthcare.com/telehealth/goodrx-launches-72-mg-wegovy-dose-self-pay-patients-399-month Most Physician Pay Up Average physician pay rose about 3% between 2024 and 2025, from $374,000 to $386,000. #providers #healthcare https://www.fiercehealthcare.com/providers/physician-compensation-3-2025-not-all-specialties-saw-raises-medscape Wakely: Exchange Enrollment Could Fall Further Wakely Consulting examined latest enrollment

Read More »
Logo

April 14, 2026

Bill Would Force Insurers To Count DTC Drugs Against Deductible, MOOP North Carolina Republican Rep. Greg Murphy, MD, has introduced a new bill that would compel insurers to apply the cost for drugs purchased from direct-to-consumer (DTC) platforms to deductibles and out-of-pocket maximums (MOOPs) in insurance. Using these platforms, patients can often find prices that cost far less out-of-pocket, especially for brand drugs, Murphy’s office said. #drugpricing #dtc #branddrugmakers #healthplans https://www.fiercehealthcare.com/regulatory/bill-seeks-force-payers-apply-dtc-drug-purchases-patient-deductibles Safety Net Hospitals Lag On Cost Reporting An analysis published in JAMA Network Open finds that hospitals serving more disadvantaged populations lag on complying with price transparency regulations.  #pricetransparency #hospitals https://www.fiercehealthcare.com/providers/hospitals-more-disadvantaged-patients-fall-short-price-transparency-study — Marc S. Ryan

Read More »
Logo

April 13, 2026

Healthcare Costs Vary Across Regions A new report titled the Health Cost Landscape from the Health Care Cost Institute found that healthcare spending per person with employer coverage was $6,711 but the figure can vary significantly by region. Spending was 70% higher than the national average in Charleston, West Virginia, while costs were 41% below the national average in Bakersfield, California. The report looked at more than 1.3 billion medical claims submitted from 2018 to 2022, with data from 38 million people. The report also found that the price of services, utilization trends and the types of services used all contribute to the spending figures. Prices were the largest driver in variation. Most of the metropolitan areas included in the study were highly concentrated hospital markets, with 88% either highly or very highly concentrated. #healthcare #costs #employercoverage https://www.fiercehealthcare.com/finance/healthcare-spending-varies-widely-between-metropolitan-areas-hcci ACCESS Winners Announced The Centers for Medicare and Medicaid Services (CMS) announced

Read More »

2027 Final Rates Out! A Modest Increase Added

CMS moves a little on rate hike for plans given troubled finances and beneficiary impacts The Centers for Medicare and Medicaid Services (CMS) has released its Final Announcement for calendar year (CY) 2027 rates and policies for Medicare Advantage (MA) and Part D. I wrote about the Advance Notice back on January 29. I will not repeat much of the technical explanations again here, but please go back to that blog for in-depth explanations of various rate-setting terms. Proposed rates tend to increase each year between the Advance Notice and Final Announcement as more data is updated from the fee-for-service (FFS) program. The plan benchmarks are based on both FFS and MA costs. Based on past history, I had predicted that rates would end up between 2% and 3% as the Effective Growth Rate (EGR) would increase markedly between the advance and final notices. In the end, the EGR actually

Read More »
Logo

April 10, 2026

New Drug PA Requirements In Government Programs Notwithstanding the voluntary prior authorization reforms, the Centers for Medicare and Medicaid Services (CMS) issued a new proposed rule that extends recent non-pharmacy prior authorization requirements to retail drug requests. In the case of retail drugs, urgent requests would have to be fulfilled in government programs within 24 hours, with all others in 72 hours. The requirement is within a broader Interoperability Standards and Prior Authorization for Drugs rule. The PA requirements are effective October 1, 2027. The rule would also require insurers to publicly report certain metrics around prior authorization, including approval and denial rates, appeal outcomes, and decision timeframes. As well, CMS is proposing to require payers to support three National Council for Prescription Drug Programs (NCPDP) standards—the SCRIPT, Formulary & Benefit (F&B), and Real-Time Prescription Benefit (RTPB) standards–beginning October 1, 2027. The proposed standards allow providers to query formulary information,

Read More »
Logo

April 9, 2026

Priority Health Overpayment Audit The Health and Human Services (HHS) Office of the Inspector General (OIG) says Priority Health may have collected at least $4.4 million in Medicare Advantage (MA) overpayments throughout 2018 and 2019. The targeted audit focused on ten high-risk diagnosis groups. Auditors found medical records did not back diagnosis codes across 252 of 300 sampled enrollee-years, prompting $828,010 in net MA overpayments — an 84% error rate. OIG says many codes were for a previous diagnosis that was no longer active. #medicareadvantage #radv #riskadjustment #overpayments https://www.beckerspayer.com/legal/priority-health-estimated-to-have-received-4-4m-in-overpayments-audit/ Wakely Details LEAD A great Wakely Consulting white paper detailing the ACO LEAD model, which will succeed ACO Reach and run from 2027–2036. LEAD will eliminate rebasing (locking in base years), expand capitation and specialist risk-sharing, integrate high-needs populations into a unified ACO structure, and offer more flexible alignment mechanisms. Benchmarking and value-based care incentives also evolve along while strengthening quality incentives

Read More »

RADV Audits For Payment Year 2020 Announced

CMS plows ahead on RADV without underlying rule On March 20, the Centers for Medicare and Medicaid Services (CMS) announced that it will proceed with Payment Year 2020 Risk Adjustment Data Validation (RADV) audits. In May 2025, CMS Administrator Dr. Mehmet Oz promised to audit every contract every year to reduce overpayments in the Medicare Advantage (MA) program. But that promise took a bit of a hit when a federal judge in September 2025 sided with Humana and struck the RADV rule finalized by the Biden administration in 2023. The judge nullified the entire rule, not just portions of it. The decision was not unexpected. The Biden administration included so many far-fetched and indefensible provisions. The court in the RADV case found that CMS did not follow the procedural requirements of the Administrative Procedure Act (APA). There were inadequate notice requirements. CMS did not justify its decisions via the comment

Read More »

Available Now

$30.00